Clinical Trials Browser

NCT05101213 2026-04-16

Study Assessing the Feasibility, Safety and Efficacy of Genetically Engineered Glucocorticoid Receptor Knock Out Virus Specific CTL Lines for Viral Infections in Immunosuppressed Cancer Patients

Phase 1 Recruiting

30 enrolled

Other hematologic neoplasm

Adenoviridae Infections, Cytomegalovirus Infections, Hematologic Neoplasms

NCT02143804 2026-04-02

exBOND

Phase 2 Withdrawn

Genitourinary

Adenoviridae Infections, Urinary Bladder Neoplasms

NCT06763965 2026-03-23

Evaluating the Safety and Efficacy of BioTTT001 in Patients With Recurrent/Progressive High-grade Glioma.

Phase 1/2 Enrolling by invitation

30 enrolled

CNS

Adenoviridae Infections, Glioma

NCT04695327 2026-03-06

TUNIMO

Phase 1 Completed

32 enrolled

Adenoviridae Infections

NCT02705196 2026-02-24

LOAd703 Oncolytic Virus Therapy for Pancreatic Cancer

Phase 1/2 Completed

51 enrolled

Gastrointestinal

Adenoviridae Infections, Neoplasms, Pancreatic Neoplasms

NCT02048332 2025-12-16

VSTs

Phase 1/2 Recruiting

750 enrolled

Adenoviridae Infections, Virus Diseases, Epstein-Barr Virus Infections

NCT02532452 2025-12-16

Third Party Viral Specific T-cells (VSTs)

Phase 2 Recruiting

750 enrolled

Adenoviridae Infections, Virus Diseases, Epstein-Barr Virus Infections

NCT06215846 2025-11-26

A Clinical Study Evaluating the Safety and Efficacy of BioTTT001 in Patients With Malignant Solid Tumors

Phase 1 Enrolling by invitation

12 enrolled

Adenoviridae Infections

NCT05271318 2025-11-03

PROTA

Phase 1/2 Recruiting

29 enrolled

Adenoviridae Infections

NCT06909110 2025-08-14

Viral Specific T-Lymphocytes to Treat Infection With Adenovirus, Cytomegalovirus or Epstein-Barr Virus in Patients With Compromised Immunity

Phase 1/2 Recruiting

25 enrolled

Adenoviridae Infections, Cytomegalovirus Infections, Epstein-Barr Virus Infections

NCT04013802 2025-08-08

TETRAVI

Phase 1 Recruiting

47 enrolled

Adenoviridae Infections, Virus Diseases, Epstein-Barr Virus Infections

NCT06926894 2025-07-31

R-MVST Cells for Treatment of Viral Infections in Children and Young Adults

Phase 1 Recruiting

18 enrolled

Adenoviridae Infections, Cytomegalovirus Infections, Immunologic Deficiency Syndromes, Epstein-Barr Virus Infections

NCT04832607 2025-07-18

TRACE

Phase 3 Recruiting

149 enrolled

Adenoviridae Infections, Cytomegalovirus Infections, Epstein-Barr Virus Infections

NCT06027879 2025-06-25

Gamma Capture

Phase 1/2 Enrolling by invitation

25 enrolled

Adenoviridae Infections, Cytomegalovirus Infections, Epstein-Barr Virus Infections

NCT03475212 2025-05-11

ACES

Phase 1/2 Active not recruiting

52 enrolled

Primary Immunodeficiency Diseases, Adenoviridae Infections, Cytomegalovirus Infections, Epstein-Barr Virus Infections